Combination of Mitoxantrone Hydrochloride Liposome with Cyclophosphamide, Vincristine and Prednisone (CMOP) in Treatment-Naive Patients with Peripheral T-Cell Lymphoma: A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical Trial
第一作者机构:[1]Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714):
Huang Hui-Qiang,Yan Gao,Jiang Ming,et al.Combination of Mitoxantrone Hydrochloride Liposome with Cyclophosphamide, Vincristine and Prednisone (CMOP) in Treatment-Naive Patients with Peripheral T-Cell Lymphoma: A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical Trial[J].BLOOD.2022,140:3762-3763.doi:10.1182/blood-2022-163343.
APA:
Huang, Hui-Qiang,Yan, Gao,Jiang, Ming,Liu, Lihong,Xiao, Qing...&Wang, Peng.(2022).Combination of Mitoxantrone Hydrochloride Liposome with Cyclophosphamide, Vincristine and Prednisone (CMOP) in Treatment-Naive Patients with Peripheral T-Cell Lymphoma: A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical Trial.BLOOD,140,
MLA:
Huang, Hui-Qiang,et al."Combination of Mitoxantrone Hydrochloride Liposome with Cyclophosphamide, Vincristine and Prednisone (CMOP) in Treatment-Naive Patients with Peripheral T-Cell Lymphoma: A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical Trial".BLOOD 140.(2022):3762-3763